IRIS
KERLERO DE ROSBO, NICOLE HENRIETTE MADELEINE CLAUDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.267
Totale 2.267
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.267
Totale 2.267
Salva come PNG Salva come JPEG
Città #
Genova 1.413
Genoa 449
Rapallo 368
Bordighera 21
Vado Ligure 16
Totale 2.267
Salva come PNG Salva come JPEG
Nome #
IFN-γ orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways 150
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 142
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis. 130
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation 122
X-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model 120
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 119
Teriflunomide treatment reduces B cells in patients with MS. 112
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis 102
Mesenchymal stem cells (MSC) as a strategy for the treatment of multiple sclerosis and other diseases of the central nervous system 101
Exploring Alzheimer's disease mouse brain through X-ray phase contrast tomography: From the cell to the organ 99
Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure 93
Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice 92
Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system. 83
SIRT6 inhibition as a therapeutic approach for treating multiple sclerosis 81
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS 80
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 78
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 78
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 65
Mesenchymal Stem Cells for the Treatment ofMultipleSclerosis 64
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cells 64
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell 64
Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation 59
Neuroinflammation induces synaptic scaling through IL-1β-mediated activation of the transcriptional repressor REST/NRSF 39
Mesenchymal stem cells instruct a beneficial phenotype in reactive astrocytes 37
Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation Status 31
Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response 30
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS 29
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 26
Hypothalamic AgRP neurons control hematopoiesis and lymphopoiesis and are activated in experimental MS 25
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 18
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 13
MSC-derived extracellular vesicles for the treatment of ALS 8
A neural connection between AgRP neurons and stromal cells in bone marrow and thymus controls lymphoid hematopoiesis and Treg generation 8
Neuronal excitability as a potential therapeutical target for Multiple Sclerosis 6
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 4
null 1
Totale 2.373
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.115
article - articoli 6.245
book - libri 0
conference - conferenze 1.466
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 404
Totale 16.230
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020561 23 8 19 39 46 63 83 45 57 104 62 12
2020/2021199 14 17 13 18 8 9 17 26 12 18 20 27
2021/2022345 24 12 15 26 32 18 10 69 20 44 14 61
2022/2023468 35 49 7 55 64 68 8 29 66 11 53 23
2023/2024342 8 28 14 35 31 56 28 41 6 7 21 67
2024/202556 56 0 0 0 0 0 0 0 0 0 0 0
Totale 2.373